Categories: News

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAESAREA, Israel, Oct. 15, 2024 /PRNewswire/ — Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee’s Oral Delivery of Biologics Platform at the 14th Annual PODD Conference – Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024.

Presentation Title: “Breakthrough Device for Oral Delivery of Biologics”
Date & Time: October 22, 2024, 2:30 PM2:45 PM
Presenter: Dr. Gil Cohen, PhD, VP R&D

Epitomee’s presentation will cover the following topics:

  • The Epitomee Platform enables oral delivery of significant amounts of large molecules, including proteins and peptides.
  • The platform dramatically boosts bioavailability, offering game-changing alternative to traditional injections.
  • Epitomee’s advanced, needle-free platform precisely transports drugs to the small intestine and across the GI wall, ensuring effective bioavailability.

The PODD Conference, in its 14th year, brings together over 800+ delegates from pharma, biotech, drug delivery, investors and academia. The event fosters collaboration across industries, to develop more effective therapies, improve the patient experience and extend the lifecycle of medicines. PODD features innovative technologies to enhance the delivery of various drug types, including proteins, peptides, oncology therapeutics, small molecules and others. This year’s annual keynote will be delivered by Dr. Robert Langer of MIT.

Join us at PODD 2024 to learn how Epitomee Medical is transforming biologics delivery.

About Epitomee Medical:
Epitomee Medical, co-founded by Shimon Eckhouse, PhD and led by CEO Dan Hashimshony, PhD, is a pioneering health solutions company, committed to advancing innovative therapies. With a focus on safety, efficacy, and improving quality of life, Epitomee leads advancements in weight management and biologic drug delivery. For more information, visit: epitomeemedical.com

Contact details: Safi Landskroner, VP of Business Development: safi@epitomeemedical.com

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/10/PODD_2024.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/10/Epitomee_Medical_Logo.jpg 

View original content to download multimedia:https://www.prnewswire.com/news-releases/epitomee-medical-to-present-the-epitomee-breakthrough-oral-delivery-platform-at-podd-2024-conference-302276347.html

SOURCE Epitomee Medical

Staff

Recent Posts

Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial

Complete Pathologic Response reported in 2 patients in the Third Cohort with cutaneous squamous cell…

32 minutes ago

ECOSEP and Tata Elxsi Announce Strategic Partnership to Transform Sports Medicine through AI

BENGALURU, India, May 7, 2025 /PRNewswire/ -- European College of Sport and Exercise Physicians (ECOSEP) and…

3 hours ago

Grant Industries Selects Labbit LIMS to Drive Digital Transformation Across Its Regulated Labs

Labbit's graph-based architecture supports the unique needs of Grant's different lab environments while unifying data…

3 hours ago

The Future of Ultrasound Reporting 

By Cecile Brosset, CEO of Sonio The landscape of ultrasound technology is rapidly evolving, driven…

20 hours ago

Beyond Medical Technologies Announces $2.5 Million Convertible Note Financing to Support Blockchain Attestation Platform

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT)…

20 hours ago

Albert Einstein College of Medicine Launches Data Science Institute

Leveraging the Power of Data to Accelerate Scientific Discovery and Improve Health in the Bronx…

20 hours ago